title: Spectra of antinuclear antibodies in patients with squamous cell carcinoma of the lung and of the head and neck.
abstract: Squamous cell carcinoma of the head and neck (HNSCC) and of the lung (LSCC) share some important risk factors, but differ substantially in terms of prognosis and treatment. A pulmonary nodule developing in patients with surgically cured HNSCC may pose a diagnostic dilemma. Markers able to distinguish these two common malignancies would be of major clinical importance. In this work we compared the spectrum of antinuclear antibodies (ANA) from 22 patients with SCCL to that of 40 patients with HNSCC. Patient sera were used to probe immunoblots of nuclear extracts from all four major lung cancer cell types, normal lung fibroblasts, cells cultured from a HNSCC, and keratinocytes cultured from the field cancerization. The ability to classify retrospectively LSCC from HNSCC based on serum ANA reactivities was determined by recursive partitioning analyses. We found that while both malignancies share reactivities to a small group of nuclear antigens, other reactivities are directed against proteins uniquely or preferentially expressed in either SCCL or in SCCHN cells. Our work shows that autoimmunity is a prominent feature of squamous cell carcinoma and suggests that molecular characterization of nuclear antigens recognized by ANAs may lead to the discovery of markers valuable to distinguish LSCC from HNSCC.
authors.affiliation: Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA. fmadrid@med.wayne.edu
authors.forename: Félix
authors.initials: F
authors.lastname: Fernández Madrid
authors.forename: Robert L
authors.initials: RL
authors.lastname: Karvonen
authors.forename: John
authors.initials: J
authors.lastname: Ensley
authors.forename: Michael
authors.initials: M
authors.lastname: Kraut
authors.forename: José L
authors.initials: JL
authors.lastname: Granda
authors.forename: Huda
authors.initials: H
authors.lastname: Alansari
authors.forename: Naimei
authors.initials: N
authors.lastname: Tang
authors.forename: John E
authors.initials: JE
authors.lastname: Tomkiel
mesh_terms: D000974:Antibodies, Antinuclear / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000276:immunology* / Q000503:physiopathology; D002294:Carcinoma, Squamous Cell / Q000276:immunology* / Q000503:physiopathology; D003937:Diagnosis, Differential; D006367:HeLa Cells; D006258:Head and Neck Neoplasms / Q000276:immunology* / Q000503:physiopathology; D006801:Humans; D015151:Immunoblotting; D015603:Keratinocytes; D008175:Lung Neoplasms / Q000276:immunology* / Q000503:physiopathology / Q000556:secondary; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D014407:Tumor Cells, Cultured
chemical_list: D000974:Antibodies, Antinuclear
references.citation: Clin Cancer Res. 2002 Mar;8(3):752-8
references.pmid: 11895905
references.citation: Anticancer Res. 1998 Nov-Dec;18(6B):4779-86
references.pmid: 9891557
references.citation: Int J Cancer. 2000 Apr 1;86(1):144-9
references.pmid: 10728609
references.citation: Nature. 1970 Aug 15;227(5259):680-5
references.pmid: 5432063
references.citation: Cancer Res. 2004 Aug 1;64(15):5089-96
references.pmid: 15289310
references.citation: Cancer Detect Prev. 2005;29(1):59-65
references.pmid: 15734219
references.citation: Thorax. 1975 Aug;30(4):367-70
references.pmid: 170702
references.citation: Cancer. 1996 May 1;77(9):1947-55
references.pmid: 8646697
references.citation: Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):557-62
references.pmid: 9806515
references.citation: Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9824-9
references.pmid: 11504947
references.citation: Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):641-8
references.pmid: 11401914
references.citation: Ann Oncol. 2004 Jan;15(1):28-32
references.pmid: 14679115
references.citation: Clin Cancer Res. 1999 Jun;5(6):1393-400
references.pmid: 10389924
references.citation: Arch Otolaryngol Head Neck Surg. 2004 Jan;130(1):98-104
references.pmid: 14732777
references.citation: Cancer Res. 1988 Jan 15;48(2):430-4
references.pmid: 2825975
references.citation: Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):754-9
references.pmid: 12874078
references.citation: Cancer. 1991 Feb 15;67(4 Suppl):1155-64
references.pmid: 1991274
references.citation: N Engl J Med. 2001 Dec 27;345(26):1890-900
references.pmid: 11756581
references.citation: J Natl Cancer Inst. 1998 Jul 1;90(13):972-7
references.pmid: 9665144
references.citation: Lung Cancer. 2003 Mar;39(3):297-301
references.pmid: 12609568
references.citation: Ann N Y Acad Sci. 2001 Sep;945:36-50
references.pmid: 11708493
references.citation: Ann N Y Acad Sci. 2003 Mar;983:298-319
references.pmid: 12724234
references.citation: Laryngoscope. 2003 Mar;113(3):393-400
references.pmid: 12616185
references.citation: Laryngoscope. 1998 Feb;108(2):250-6
references.pmid: 9473077
references.citation: Eur J Cancer Prev. 2001 Jun;10(3):213-26
references.pmid: 11432708
references.citation: Cancer Res. 1992 Aug 1;52(15):4168-74
references.pmid: 1322237
references.citation: Obstet Gynecol. 1971 Dec;38(6):945-9
references.pmid: 4942173
references.citation: Thorax. 2003 Sep;58(9):784-9
references.pmid: 12947138
references.citation: Cancer Res. 1993 Oct 1;53(19):4477-80
references.pmid: 8402617
references.citation: J Clin Invest. 1997 Oct 15;100(8):2133-7
references.pmid: 9329980
references.citation: Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):499-504
references.pmid: 9232336
references.citation: Arch Otolaryngol Head Neck Surg. 2003 Mar;129(3):367-8
references.pmid: 12622553
references.citation: J Natl Cancer Inst. 1999 Jul 21;91(14):1194-210
references.pmid: 10413421
references.citation: Medicine (Baltimore). 1992 Mar;71(2):59-72
references.pmid: 1312211
references.citation: Oncogene. 1999 Jan 21;18(3):643-50
references.pmid: 9989814
references.citation: Chest. 1999 Dec;116(6 Suppl):493S-496S
references.pmid: 10619517
references.citation: Clin Cancer Res. 1999 Nov;5(11):3476-82
references.pmid: 10589761
references.citation: Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
references.pmid: 388439
references.citation: Cancer. 1982 Oct 1;50(7):1289-93
references.pmid: 6286090
references.citation: Ann Oncol. 1999;10 Suppl 5:S7-11
references.pmid: 10582132